EASL Campus

ABU SALEH MD SADEQUL ISLAM commented on Non-alcoholic fatty liver diseas…

1 year ago

Non-alcoholic fatty liver disease: A patient guideline

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which ha...

2

1

Comment
ABU SALEH MD SADEQUL ISLAM commented on Liver Cancer Explained

1 year ago

Liver Cancer Explained

Liver cancer is the third leading cause of cancer-related deaths worldwide and the primary cause of death for patients with cirrhosis. Most of liver cancers are hepatocellular carcinomas, however some patients develop intrahepatic cholangiocarcinomas (ICC) or rare tumours in non-cirrhotic livers. Chronic liver diseases, alcohol c...

1

1

Comment
created an event

1 year ago
ABU SALEH MD SADEQUL ISLAM commented on ILC 2021 Takeaways – Public heal…

1 year ago

ILC 2021 Takeaways – Public health

As part of the International Liver Congress (ILC) 2021, the EASL Takeaways take a look at key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective. This session, presented by Professors Maria Buti, Shira Zelber-Sagi and Antonio Craxì, explores prominent themes f...

1

1

Read more about ILC 2021 Takeaways – Public health
Log in to post comments

Comment
liuyuanchun33@outlook.com posted

1 year ago
LUIZ OTAVIO Cangussu posted

1 year ago
LUIZ OTAVIO Cangussu posted

1 year ago
ABU SALEH MD SADEQUL ISLAM commented on EASL Clinical Practice Guideline…

1 year ago

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated with a significant risk of maternal and fetal morbidity and mortality. Thus, the European Ass...

0

1

Comment
Rehana Begum commented on Mycophenolate Mofetil as first l…

1 year ago
Vincenzo Mazzaferro commented on EASL Studio - Advances in system…

1 year ago

EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)

EASL Studio - Advances in systemic treatments in liver cancer   Josep Llovet (Moderator), Massimo Iavarone (Faculty), Matthias Pinter (Faculty), Jessica Zucman-Rossi (Faculty)

0

1

Read more about EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)
Log in to post comments

Comment
MOHAMED Seco posted

1 year ago
drkhan008@gmail.com commented on EASL Studio S6 E12: Do we care e…

1 year ago

EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

Description Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI). In this episode, the speakers explore the importance of DHILI, assess recent advancements, and deliberate on the obstacles hindering further progress in addressing this pressing healthcare c...

0

1

Read more about EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?
Log in to post comments

Comment
created an event

1 year ago
created an event

1 year ago
created an event

1 year ago
created an event

2 years ago
created an event

2 years ago
created an event

2 years ago
created an event

2 years ago
created an event

2 years ago

EASL Community Feed

Non-alcoholic fatty liver disease: A patient guideline

Liver Cancer Explained

ILC 2021 Takeaways – Public health

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)

EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

Community Stream